Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(ctDNA). Showing records 1 – 15 of 15 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


University of Oxford

1. Winter, Helen. Novel imaging and circulating biomarkers in hepatic malignancies.

Degree: PhD, 2020, University of Oxford

 Colorectal cancer (CRC) that has metastasised to the liver has a median survival of less than 24 months unless patients have resectable disease. Liver-directed therapies… (more)

Subjects/Keywords: ctDNA; Colon (Anatomy) – Cancer; SIRT

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Winter, H. (2020). Novel imaging and circulating biomarkers in hepatic malignancies. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:97aeb588-9d6e-4c1c-ab00-d9296c4129aa ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.813609

Chicago Manual of Style (16th Edition):

Winter, Helen. “Novel imaging and circulating biomarkers in hepatic malignancies.” 2020. Doctoral Dissertation, University of Oxford. Accessed April 18, 2021. http://ora.ox.ac.uk/objects/uuid:97aeb588-9d6e-4c1c-ab00-d9296c4129aa ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.813609.

MLA Handbook (7th Edition):

Winter, Helen. “Novel imaging and circulating biomarkers in hepatic malignancies.” 2020. Web. 18 Apr 2021.

Vancouver:

Winter H. Novel imaging and circulating biomarkers in hepatic malignancies. [Internet] [Doctoral dissertation]. University of Oxford; 2020. [cited 2021 Apr 18]. Available from: http://ora.ox.ac.uk/objects/uuid:97aeb588-9d6e-4c1c-ab00-d9296c4129aa ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.813609.

Council of Science Editors:

Winter H. Novel imaging and circulating biomarkers in hepatic malignancies. [Doctoral Dissertation]. University of Oxford; 2020. Available from: http://ora.ox.ac.uk/objects/uuid:97aeb588-9d6e-4c1c-ab00-d9296c4129aa ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.813609


University of Melbourne

2. Yeh, Paul Sung-Hao. Molecular monitoring and screening in haematological malignancies.

Degree: 2018, University of Melbourne

 Advances in genomic sequencing have improved clinical outcomes in patients with haematological malignancies by allowing more refined diagnostic and prognostic stratification. However, significant challenges still… (more)

Subjects/Keywords: molecular; ctDNA; myelodysplastic syndrome; chronic lymphocytic leukaemia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yeh, P. S. (2018). Molecular monitoring and screening in haematological malignancies. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/217352

Chicago Manual of Style (16th Edition):

Yeh, Paul Sung-Hao. “Molecular monitoring and screening in haematological malignancies.” 2018. Doctoral Dissertation, University of Melbourne. Accessed April 18, 2021. http://hdl.handle.net/11343/217352.

MLA Handbook (7th Edition):

Yeh, Paul Sung-Hao. “Molecular monitoring and screening in haematological malignancies.” 2018. Web. 18 Apr 2021.

Vancouver:

Yeh PS. Molecular monitoring and screening in haematological malignancies. [Internet] [Doctoral dissertation]. University of Melbourne; 2018. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/11343/217352.

Council of Science Editors:

Yeh PS. Molecular monitoring and screening in haematological malignancies. [Doctoral Dissertation]. University of Melbourne; 2018. Available from: http://hdl.handle.net/11343/217352


University of Toronto

3. Paramathas, Sangeetha. Investigating the use of circulating tumor DNA for cancer surveillance and early detection in (pediatric) sarcomas and Li-Fraumeni Syndrome.

Degree: PhD, 2020, University of Toronto

 Circulating tumor DNA (ctDNA) is a biomarker that has been shown to be valuable in a variety of contexts in clinical oncology such as determining… (more)

Subjects/Keywords: ctDNA; Early Detection; Li-Fraumeni Syndrome; Liquid Biopsies; Sarcomas; Surveillance; 0992

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Paramathas, S. (2020). Investigating the use of circulating tumor DNA for cancer surveillance and early detection in (pediatric) sarcomas and Li-Fraumeni Syndrome. (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/101212

Chicago Manual of Style (16th Edition):

Paramathas, Sangeetha. “Investigating the use of circulating tumor DNA for cancer surveillance and early detection in (pediatric) sarcomas and Li-Fraumeni Syndrome.” 2020. Doctoral Dissertation, University of Toronto. Accessed April 18, 2021. http://hdl.handle.net/1807/101212.

MLA Handbook (7th Edition):

Paramathas, Sangeetha. “Investigating the use of circulating tumor DNA for cancer surveillance and early detection in (pediatric) sarcomas and Li-Fraumeni Syndrome.” 2020. Web. 18 Apr 2021.

Vancouver:

Paramathas S. Investigating the use of circulating tumor DNA for cancer surveillance and early detection in (pediatric) sarcomas and Li-Fraumeni Syndrome. [Internet] [Doctoral dissertation]. University of Toronto; 2020. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/1807/101212.

Council of Science Editors:

Paramathas S. Investigating the use of circulating tumor DNA for cancer surveillance and early detection in (pediatric) sarcomas and Li-Fraumeni Syndrome. [Doctoral Dissertation]. University of Toronto; 2020. Available from: http://hdl.handle.net/1807/101212


University of Cambridge

4. Heider, Katrin. Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer.

Degree: PhD, 2020, University of Cambridge

 Liquid biopsies, using analytes such as circulating tumour DNA (ctDNA), can detect and quantify cancer in a minimally invasive way and can provide information on… (more)

Subjects/Keywords: ctDNA; blood spots; cfDNA; liquid biopsy; NSCLC; NGS; cancer; early detection

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Heider, K. (2020). Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/303618

Chicago Manual of Style (16th Edition):

Heider, Katrin. “Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer.” 2020. Doctoral Dissertation, University of Cambridge. Accessed April 18, 2021. https://www.repository.cam.ac.uk/handle/1810/303618.

MLA Handbook (7th Edition):

Heider, Katrin. “Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer.” 2020. Web. 18 Apr 2021.

Vancouver:

Heider K. Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2021 Apr 18]. Available from: https://www.repository.cam.ac.uk/handle/1810/303618.

Council of Science Editors:

Heider K. Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://www.repository.cam.ac.uk/handle/1810/303618


University of Cambridge

5. Heider, Katrin. Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer.

Degree: PhD, 2020, University of Cambridge

 Liquid biopsies, using analytes such as circulating tumour DNA (ctDNA), can detect and quantify cancer in a minimally invasive way and can provide information on… (more)

Subjects/Keywords: ctDNA; blood spots; cfDNA; liquid biopsy; NSCLC; NGS; cancer; early detection

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Heider, K. (2020). Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer. (Doctoral Dissertation). University of Cambridge. Retrieved from https://doi.org/10.17863/CAM.50695 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.801898

Chicago Manual of Style (16th Edition):

Heider, Katrin. “Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer.” 2020. Doctoral Dissertation, University of Cambridge. Accessed April 18, 2021. https://doi.org/10.17863/CAM.50695 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.801898.

MLA Handbook (7th Edition):

Heider, Katrin. “Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer.” 2020. Web. 18 Apr 2021.

Vancouver:

Heider K. Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2021 Apr 18]. Available from: https://doi.org/10.17863/CAM.50695 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.801898.

Council of Science Editors:

Heider K. Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://doi.org/10.17863/CAM.50695 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.801898

6. Tzanikou, Eleni. Ανάπτυξη και επικύρωση υπερ-ευαίσθητων συνοδών διαγνωστικών εξετάσεων στα πλαίσια της υγρής βιοψίας (κυκλοφορούντα καρκινικά κύτταρα και ελεύθερο-κυττάρων DNA).

Degree: 2019, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

 During the last years, liquid biopsy has overcome the limitations of tumor biopsy, changinh significantly the therapeutic strategy in cancer patients. Liquid biopsy is based… (more)

Subjects/Keywords: Υγρή βιοψία; Κυκλοφορούντα καρκινικά κύτταρα; Εξωκυττάριο καρκινικό DNA (ctDNA); DNA μεταλλάξεις; Liquid biopsy; Circulating tumor cells (CTCs); Circulating tumor DNA (ctDNA); DNA mutations; PIK3CA; ESR1; PIM-1; BRAF

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tzanikou, E. (2019). Ανάπτυξη και επικύρωση υπερ-ευαίσθητων συνοδών διαγνωστικών εξετάσεων στα πλαίσια της υγρής βιοψίας (κυκλοφορούντα καρκινικά κύτταρα και ελεύθερο-κυττάρων DNA). (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/46480

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tzanikou, Eleni. “Ανάπτυξη και επικύρωση υπερ-ευαίσθητων συνοδών διαγνωστικών εξετάσεων στα πλαίσια της υγρής βιοψίας (κυκλοφορούντα καρκινικά κύτταρα και ελεύθερο-κυττάρων DNA).” 2019. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed April 18, 2021. http://hdl.handle.net/10442/hedi/46480.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tzanikou, Eleni. “Ανάπτυξη και επικύρωση υπερ-ευαίσθητων συνοδών διαγνωστικών εξετάσεων στα πλαίσια της υγρής βιοψίας (κυκλοφορούντα καρκινικά κύτταρα και ελεύθερο-κυττάρων DNA).” 2019. Web. 18 Apr 2021.

Vancouver:

Tzanikou E. Ανάπτυξη και επικύρωση υπερ-ευαίσθητων συνοδών διαγνωστικών εξετάσεων στα πλαίσια της υγρής βιοψίας (κυκλοφορούντα καρκινικά κύτταρα και ελεύθερο-κυττάρων DNA). [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2019. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/10442/hedi/46480.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Tzanikou E. Ανάπτυξη και επικύρωση υπερ-ευαίσθητων συνοδών διαγνωστικών εξετάσεων στα πλαίσια της υγρής βιοψίας (κυκλοφορούντα καρκινικά κύτταρα και ελεύθερο-κυττάρων DNA). [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2019. Available from: http://hdl.handle.net/10442/hedi/46480

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cambridge

7. Wan, Jonathan Chee Ming. Monitoring trace levels of ctDNA using integration of variant reads.

Degree: PhD, 2019, University of Cambridge

 In patients with early-stage cancer, ctDNA detection rates can be low due to the presence of few or no copies of any individual mutation in… (more)

Subjects/Keywords: liquid biopsy; circulating tumour DNA; ctDNA; cancer genomics; bioinformatics; cancer; melanoma; circulating nucleic acids

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wan, J. C. M. (2019). Monitoring trace levels of ctDNA using integration of variant reads. (Doctoral Dissertation). University of Cambridge. Retrieved from https://doi.org/10.17863/CAM.40703 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.782813

Chicago Manual of Style (16th Edition):

Wan, Jonathan Chee Ming. “Monitoring trace levels of ctDNA using integration of variant reads.” 2019. Doctoral Dissertation, University of Cambridge. Accessed April 18, 2021. https://doi.org/10.17863/CAM.40703 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.782813.

MLA Handbook (7th Edition):

Wan, Jonathan Chee Ming. “Monitoring trace levels of ctDNA using integration of variant reads.” 2019. Web. 18 Apr 2021.

Vancouver:

Wan JCM. Monitoring trace levels of ctDNA using integration of variant reads. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2021 Apr 18]. Available from: https://doi.org/10.17863/CAM.40703 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.782813.

Council of Science Editors:

Wan JCM. Monitoring trace levels of ctDNA using integration of variant reads. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://doi.org/10.17863/CAM.40703 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.782813


University of Cambridge

8. Wan, Jonathan Chee Ming. Monitoring trace levels of ctDNA using integration of variant reads.

Degree: PhD, 2019, University of Cambridge

 In patients with early-stage cancer, ctDNA detection rates can be low due to the presence of few or no copies of any individual mutation in… (more)

Subjects/Keywords: liquid biopsy; circulating tumour DNA; ctDNA; cancer genomics; bioinformatics; cancer; melanoma; circulating nucleic acids

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wan, J. C. M. (2019). Monitoring trace levels of ctDNA using integration of variant reads. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/293567

Chicago Manual of Style (16th Edition):

Wan, Jonathan Chee Ming. “Monitoring trace levels of ctDNA using integration of variant reads.” 2019. Doctoral Dissertation, University of Cambridge. Accessed April 18, 2021. https://www.repository.cam.ac.uk/handle/1810/293567.

MLA Handbook (7th Edition):

Wan, Jonathan Chee Ming. “Monitoring trace levels of ctDNA using integration of variant reads.” 2019. Web. 18 Apr 2021.

Vancouver:

Wan JCM. Monitoring trace levels of ctDNA using integration of variant reads. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2021 Apr 18]. Available from: https://www.repository.cam.ac.uk/handle/1810/293567.

Council of Science Editors:

Wan JCM. Monitoring trace levels of ctDNA using integration of variant reads. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://www.repository.cam.ac.uk/handle/1810/293567


University of Otago

9. Parackal, Sarah Grace. The Development of Circulating Tumour DNA as a Clinical Surveillance Tool for New Zealand Breast Cancer Patients .

Degree: University of Otago

 Breast cancer is a heterogeneous group of diseases where metastatic spread is the major cause of death. Surveillance of treatment response and tumour burden is… (more)

Subjects/Keywords: ctDNA; New Zealand; Breast Cancer; Clinical Tool

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Parackal, S. G. (n.d.). The Development of Circulating Tumour DNA as a Clinical Surveillance Tool for New Zealand Breast Cancer Patients . (Masters Thesis). University of Otago. Retrieved from http://hdl.handle.net/10523/8071

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Chicago Manual of Style (16th Edition):

Parackal, Sarah Grace. “The Development of Circulating Tumour DNA as a Clinical Surveillance Tool for New Zealand Breast Cancer Patients .” Masters Thesis, University of Otago. Accessed April 18, 2021. http://hdl.handle.net/10523/8071.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

MLA Handbook (7th Edition):

Parackal, Sarah Grace. “The Development of Circulating Tumour DNA as a Clinical Surveillance Tool for New Zealand Breast Cancer Patients .” Web. 18 Apr 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Parackal SG. The Development of Circulating Tumour DNA as a Clinical Surveillance Tool for New Zealand Breast Cancer Patients . [Internet] [Masters thesis]. University of Otago; [cited 2021 Apr 18]. Available from: http://hdl.handle.net/10523/8071.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Council of Science Editors:

Parackal SG. The Development of Circulating Tumour DNA as a Clinical Surveillance Tool for New Zealand Breast Cancer Patients . [Masters Thesis]. University of Otago; Available from: http://hdl.handle.net/10523/8071

Note: this citation may be lacking information needed for this citation format:
No year of publication.

10. Sefrioui, David. Aspect pré analytique et intérêt clinique de la détection d'ADN tumoral circulant par PCR digitale en oncologie digestive : Pre-analytical aspect and clinical interest of the detection of tumour DNA circulating by digital PCR in digestive oncology.

Degree: Docteur es, Biologie cellulaire, 2017, Normandie

L'ADN tumoral circulant (ADNtumc) est apparu depuis plusieurs années comme un biomarqueur prometteur susceptible d'apporter des informations permettant l'optimisation de la prise en charge du… (more)

Subjects/Keywords: ADN tumoral circulant (ADNtumc); Digitale PCR (dPCR); Biomarqueur; Mutations KRAS; Oncologie digestive; Circulating tumor DNA (ctDNA); Biomarker; 610

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sefrioui, D. (2017). Aspect pré analytique et intérêt clinique de la détection d'ADN tumoral circulant par PCR digitale en oncologie digestive : Pre-analytical aspect and clinical interest of the detection of tumour DNA circulating by digital PCR in digestive oncology. (Doctoral Dissertation). Normandie. Retrieved from http://www.theses.fr/2017NORMR075

Chicago Manual of Style (16th Edition):

Sefrioui, David. “Aspect pré analytique et intérêt clinique de la détection d'ADN tumoral circulant par PCR digitale en oncologie digestive : Pre-analytical aspect and clinical interest of the detection of tumour DNA circulating by digital PCR in digestive oncology.” 2017. Doctoral Dissertation, Normandie. Accessed April 18, 2021. http://www.theses.fr/2017NORMR075.

MLA Handbook (7th Edition):

Sefrioui, David. “Aspect pré analytique et intérêt clinique de la détection d'ADN tumoral circulant par PCR digitale en oncologie digestive : Pre-analytical aspect and clinical interest of the detection of tumour DNA circulating by digital PCR in digestive oncology.” 2017. Web. 18 Apr 2021.

Vancouver:

Sefrioui D. Aspect pré analytique et intérêt clinique de la détection d'ADN tumoral circulant par PCR digitale en oncologie digestive : Pre-analytical aspect and clinical interest of the detection of tumour DNA circulating by digital PCR in digestive oncology. [Internet] [Doctoral dissertation]. Normandie; 2017. [cited 2021 Apr 18]. Available from: http://www.theses.fr/2017NORMR075.

Council of Science Editors:

Sefrioui D. Aspect pré analytique et intérêt clinique de la détection d'ADN tumoral circulant par PCR digitale en oncologie digestive : Pre-analytical aspect and clinical interest of the detection of tumour DNA circulating by digital PCR in digestive oncology. [Doctoral Dissertation]. Normandie; 2017. Available from: http://www.theses.fr/2017NORMR075


Edith Cowan University

11. McEvoy, Ashleigh Cavell. Circulating tumour DNA: A non-invasive biomarker for melanoma.

Degree: 2018, Edith Cowan University

 Cutaneous melanoma accounts for 90% of all skin cancer deaths (Balch et al., 2010) and is responsible for 3.6% of deaths from cancer in Australia… (more)

Subjects/Keywords: melanoma; cell free DNA; cfDNA; circulating tumor DNA; ctDNA; Analytical, Diagnostic and Therapeutic Techniques and Equipment; Medical Pathology; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McEvoy, A. C. (2018). Circulating tumour DNA: A non-invasive biomarker for melanoma. (Thesis). Edith Cowan University. Retrieved from https://ro.ecu.edu.au/theses/2064

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

McEvoy, Ashleigh Cavell. “Circulating tumour DNA: A non-invasive biomarker for melanoma.” 2018. Thesis, Edith Cowan University. Accessed April 18, 2021. https://ro.ecu.edu.au/theses/2064.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

McEvoy, Ashleigh Cavell. “Circulating tumour DNA: A non-invasive biomarker for melanoma.” 2018. Web. 18 Apr 2021.

Vancouver:

McEvoy AC. Circulating tumour DNA: A non-invasive biomarker for melanoma. [Internet] [Thesis]. Edith Cowan University; 2018. [cited 2021 Apr 18]. Available from: https://ro.ecu.edu.au/theses/2064.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

McEvoy AC. Circulating tumour DNA: A non-invasive biomarker for melanoma. [Thesis]. Edith Cowan University; 2018. Available from: https://ro.ecu.edu.au/theses/2064

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

12. Zarkavelis, Georgios. Ανίχνευση του μεταλλαγμένου γονιδίου KRAS σε κυκλοφορούν ελεύθερο DNA πλάσματος και του μεταγράφου του σε αιμοπετάλια ασθενών με καρκίνο του παχέος εντέρου και μελέτη της κλινικής τους χρησιμότητας στην παρακολούθηση της νόσου.

Degree: 2019, University of Ioannina; Πανεπιστήμιο Ιωαννίνων

BACKGROUND: Liquid biopsies are emerging as attractive alternatives to classic tumor tissue biopsyproviding access to the molecular signature of the tumor while avoiding interventional techniques… (more)

Subjects/Keywords: Υγρές βιοψίες; Καρκίνος παχέος εντέρου; Κυκλοφορούν καρκινικό DNA; Liquid biopsies; Colorectal cancer; Circulating tumor DNA (ctDNA)

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zarkavelis, G. (2019). Ανίχνευση του μεταλλαγμένου γονιδίου KRAS σε κυκλοφορούν ελεύθερο DNA πλάσματος και του μεταγράφου του σε αιμοπετάλια ασθενών με καρκίνο του παχέος εντέρου και μελέτη της κλινικής τους χρησιμότητας στην παρακολούθηση της νόσου. (Thesis). University of Ioannina; Πανεπιστήμιο Ιωαννίνων. Retrieved from http://hdl.handle.net/10442/hedi/46691

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zarkavelis, Georgios. “Ανίχνευση του μεταλλαγμένου γονιδίου KRAS σε κυκλοφορούν ελεύθερο DNA πλάσματος και του μεταγράφου του σε αιμοπετάλια ασθενών με καρκίνο του παχέος εντέρου και μελέτη της κλινικής τους χρησιμότητας στην παρακολούθηση της νόσου.” 2019. Thesis, University of Ioannina; Πανεπιστήμιο Ιωαννίνων. Accessed April 18, 2021. http://hdl.handle.net/10442/hedi/46691.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zarkavelis, Georgios. “Ανίχνευση του μεταλλαγμένου γονιδίου KRAS σε κυκλοφορούν ελεύθερο DNA πλάσματος και του μεταγράφου του σε αιμοπετάλια ασθενών με καρκίνο του παχέος εντέρου και μελέτη της κλινικής τους χρησιμότητας στην παρακολούθηση της νόσου.” 2019. Web. 18 Apr 2021.

Vancouver:

Zarkavelis G. Ανίχνευση του μεταλλαγμένου γονιδίου KRAS σε κυκλοφορούν ελεύθερο DNA πλάσματος και του μεταγράφου του σε αιμοπετάλια ασθενών με καρκίνο του παχέος εντέρου και μελέτη της κλινικής τους χρησιμότητας στην παρακολούθηση της νόσου. [Internet] [Thesis]. University of Ioannina; Πανεπιστήμιο Ιωαννίνων; 2019. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/10442/hedi/46691.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zarkavelis G. Ανίχνευση του μεταλλαγμένου γονιδίου KRAS σε κυκλοφορούν ελεύθερο DNA πλάσματος και του μεταγράφου του σε αιμοπετάλια ασθενών με καρκίνο του παχέος εντέρου και μελέτη της κλινικής τους χρησιμότητας στην παρακολούθηση της νόσου. [Thesis]. University of Ioannina; Πανεπιστήμιο Ιωαννίνων; 2019. Available from: http://hdl.handle.net/10442/hedi/46691

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

13. Parisi, Cleo. Development and clinical application of methods for the molecular characterisation of circulating tumour cells (CTCs).

Degree: 2016, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

Molecular information extracted from circulating tumour cells (CTCs) and circulating tumour DNA(ctDNA), the so-called “liquid biopsy”, offers the possibility to characterise the evolution of a… (more)

Subjects/Keywords: Καρκίνος μαστού; Κυκλοφορούντα καρκινικά κύτταρα (CTCs); Κυκλοφορούν καρκινικό DNA (ctDNA); Μεθυλίωση του DNA; Υγρή συστοιχία σφαιριδίων; Breast cancer; Circulating tumor cells (CTCs); Circulating tumor DNA (ctDNA); DNA methylation; Liquid bead array

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Parisi, C. (2016). Development and clinical application of methods for the molecular characterisation of circulating tumour cells (CTCs). (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/47043

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Parisi, Cleo. “Development and clinical application of methods for the molecular characterisation of circulating tumour cells (CTCs).” 2016. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed April 18, 2021. http://hdl.handle.net/10442/hedi/47043.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Parisi, Cleo. “Development and clinical application of methods for the molecular characterisation of circulating tumour cells (CTCs).” 2016. Web. 18 Apr 2021.

Vancouver:

Parisi C. Development and clinical application of methods for the molecular characterisation of circulating tumour cells (CTCs). [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2016. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/10442/hedi/47043.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Parisi C. Development and clinical application of methods for the molecular characterisation of circulating tumour cells (CTCs). [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2016. Available from: http://hdl.handle.net/10442/hedi/47043

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Western Ontario

14. Patel, Krupal Bhupendrabhai. Detection of Circulating Thyroid Tumor DNA in Patients with Thyroid Nodules.

Degree: 2015, University of Western Ontario

 This study was conducted to determine the feasibility of detecting BRAF(V600E) circulating tumor DNA (ctDNA) in the plasma of patients with thyroid nodules, with the… (more)

Subjects/Keywords: Circulating tumor DNA; cell free DNA; ctDNA; thyroid cancer; thyroid nodule; BRAF(V600E); Endocrinology, Diabetes, and Metabolism; Otolaryngology; Surgery; Translational Medical Research

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Patel, K. B. (2015). Detection of Circulating Thyroid Tumor DNA in Patients with Thyroid Nodules. (Thesis). University of Western Ontario. Retrieved from https://ir.lib.uwo.ca/etd/3644

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Patel, Krupal Bhupendrabhai. “Detection of Circulating Thyroid Tumor DNA in Patients with Thyroid Nodules.” 2015. Thesis, University of Western Ontario. Accessed April 18, 2021. https://ir.lib.uwo.ca/etd/3644.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Patel, Krupal Bhupendrabhai. “Detection of Circulating Thyroid Tumor DNA in Patients with Thyroid Nodules.” 2015. Web. 18 Apr 2021.

Vancouver:

Patel KB. Detection of Circulating Thyroid Tumor DNA in Patients with Thyroid Nodules. [Internet] [Thesis]. University of Western Ontario; 2015. [cited 2021 Apr 18]. Available from: https://ir.lib.uwo.ca/etd/3644.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Patel KB. Detection of Circulating Thyroid Tumor DNA in Patients with Thyroid Nodules. [Thesis]. University of Western Ontario; 2015. Available from: https://ir.lib.uwo.ca/etd/3644

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Otago

15. Cocadiz, Judy Ann. Multiplex ddPCR for the detection of tumour-specific mutations in ctDNA .

Degree: University of Otago

 Circulating tumour DNA (ctDNA) are short extracellular DNA fragments that have been explored by a number of studies to potentially reflect a more complete representation… (more)

Subjects/Keywords: Colorectal Cancer; Breast Cancer; Circulating tumour DNA; ctDNA; Multiplex droplet digital PCR; ddPCR; Targeted Next Generation Sequencing; NGS

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cocadiz, J. A. (n.d.). Multiplex ddPCR for the detection of tumour-specific mutations in ctDNA . (Masters Thesis). University of Otago. Retrieved from http://hdl.handle.net/10523/10062

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Chicago Manual of Style (16th Edition):

Cocadiz, Judy Ann. “Multiplex ddPCR for the detection of tumour-specific mutations in ctDNA .” Masters Thesis, University of Otago. Accessed April 18, 2021. http://hdl.handle.net/10523/10062.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

MLA Handbook (7th Edition):

Cocadiz, Judy Ann. “Multiplex ddPCR for the detection of tumour-specific mutations in ctDNA .” Web. 18 Apr 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Cocadiz JA. Multiplex ddPCR for the detection of tumour-specific mutations in ctDNA . [Internet] [Masters thesis]. University of Otago; [cited 2021 Apr 18]. Available from: http://hdl.handle.net/10523/10062.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Council of Science Editors:

Cocadiz JA. Multiplex ddPCR for the detection of tumour-specific mutations in ctDNA . [Masters Thesis]. University of Otago; Available from: http://hdl.handle.net/10523/10062

Note: this citation may be lacking information needed for this citation format:
No year of publication.

.